Stereo Labs Private Limited
About Stereo Labs Private Limited
Data last updated:
Stereo Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2019PTC130220. Its GSTIN is 36ABBCS5288D1Z8 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nandini Vemula and Venkata Narayana Vemula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 5 – 5 – 35/207/C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.46 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹1,495 (net margin 0%) and EBITDA of -₹1,495 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 58% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No 5 – 5 – 35/207/C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Stereo Labs Private Limited
The main business activity of Stereo Labs is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stereo Labs Private Limited FY 2025 filings available
Stereo Labs Private Limited reported revenue of ₹67.46 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Stereo Labs Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 58% over five years, including 4% growth in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stereo Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1,495 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1,495 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stereo Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stereo Labs are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Stereo Labs Private Limited
Stereo Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandini Vemula | Director | 09 Jan 2024 | 2 Years 9 Months | Current |
| Venkata Narayana Vemula Also directs: Any Pep Pharma Private Limited, Chemieblocks India Private Limited, Venkatasai Lifesciences Private Limited and 1 more | Director | 01 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Stereo Labs Private Limited
Stereo Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| PJS Pharma Private Limited | ₹70.55 Lakh (FY 2023) | •••• | •••• | 5595.0% | •••• | Hyderabad, Telangana, India |
| Clinomic Center for Clinical Research Private Limited | ₹70.42 Lakh (FY 2024) | •••• | •••• | 95.0% | •••• | Thane, Maharashtra, India |
| Kentron Biotechnology Private Limited | ₹70.36 Lakh (FY 2020) | •••• | •••• | -61.0% | •••• | Bangalore, Karnataka, India |
| Leintz Pharmaceuticals and Chemicals Private Limited | ₹69.21 Lakh (FY 2018) | •••• | •••• | 24.0% | •••• | Bangalore, Karnataka, India |
| Ergam Life Sciences Private Limited | ₹67.84 Lakh (FY 2024) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
| Stereo Labs Private Limited this company | ₹67.46 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
| Jansat Labs Private Limited | ₹67.07 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Positive Fertility Foundation | ₹65.09 Lakh (FY 2025) | •••• | •••• | 222.0% | •••• | Secunderabad, Telangana, India |
| Sgpharma Global Private Limited | ₹64.31 Lakh (FY 2025) | •••• | •••• | 4077.0% | •••• | Mumbai, Maharashtra, India |
| Synflix Pharmaceutical Private Limited | ₹63.52 Lakh (FY 2025) | •••• | •••• | 139.0% | •••• | Chennai, Tamil Nadu, India |
| Tara Lifescience Private Limited | ₹62.02 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Stereo Labs by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Stereo Labs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stereo Labs Private Limited
Stereo Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Stereo Labs Private Limited
Employment history and EPFO contributions of people linked to Stereo Labs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stereo Labs Private Limited
Stereo Labs Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Nandini Vemula was appointed as Director on 09 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Stereo Labs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stereo Labs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stereo Labs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stereo Labs Private Limited
Stereo Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS5288D1Z8 | Telangana | Active | 29 Apr 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stereo Labs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stereo Labs Private Limited
Stereo Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 2019 (7+ years old) and is registered under CIN U24100TG2019PTC130220.
Stereo Labs reported revenue of ₹67.46 Lakh for FY 2025 (up 4% YoY).
Stereo Labs has 2 current directors:
- Nandini Vemula - Director
- Venkata Narayana Vemula - Director
Stereo Labs reported a net loss of ₹1,495 (net margin 0%) and EBITDA of -₹1,495 (EBITDA margin 0%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stereo Labs is 58% over five years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stereo Labs is 36ABBCS5288D1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Stereo Labs is U24100TG2019PTC130220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stereo Labs was incorporated on 01 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Stereo Labs by revenue are PJS Pharma Private Limited, Clinomic Center for Clinical Research Private Limited, Kentron Biotechnology Private Limited, Leintz Pharmaceuticals and Chemicals Private Limited, Ergam Life Sciences Private Limited and 5 more, all in the Pharma industry (Contract Research).
Nandini Vemula was appointed as Director on 09 Jan 2024. Ravikumar Chukka ceased to be Director on 09 Jan 2024. Venkata Narayana Vemula was appointed as Director on 01 Feb 2019.
The registered office of Stereo Labs is at H No 5 – 5 – 35207C Plot No 12 Sakthipuram Prasanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.